Schenk Desiree, Song Gang, Ke Yue, Wang Zhaohui
Department of Research and Development, Pillar Biosciences, Natick, Massachusetts, United States of America.
PLoS One. 2017 Jul 12;12(7):e0181062. doi: 10.1371/journal.pone.0181062. eCollection 2017.
Current PCR-based target enrichment methods for next generation sequencing (NGS) of overlapping amplicons often requires separate PCR reactions and subsequent pooling of amplicons from the different reactions. The study presents a novel method, deemed stem-loop inhibition mediated amplification (SLIMamp), for amplifying overlapping or tiled amplicons in a single multiplex PCR reaction. During a SLIMamp PCR reaction, a stem loop structure formed by the overlapping amplicon suppresses additional amplification of itself by preventing the annealing of the primers. Using the SLIMamp strategy, we designed a next-generation sequencing (NGS) assay to enrich the exon regions of BRCA1 and BRCA2 for sequencing on an Illumina MiSeq system. We used 35 cell line DNAs and 6 patient blood DNAs in the study to evaluate the assay performance. For each sample, all targeted regions were successfully amplified and sequenced with excellent coverage uniformity and specificity. >99% of the total sequencing reads were mapped to the human reference genome (hg19) and >99% of the mapped reads were on the targeted exons. >98% of bases were covered at >0.20x of the mean coverage and >99% are covered at >0.15x of the mean depth. Among 34 independently sequenced samples, all variants were reliably detected with no false positives or false negatives. SLIMamp provides a robust method for single-tube multiplex PCR amplification of numerous, overlapping amplicons that tile for targeted next-generation sequencing.
当前用于下一代测序(NGS)的基于聚合酶链式反应(PCR)的重叠扩增子靶向富集方法通常需要单独的PCR反应,随后将来自不同反应的扩增子进行混合。本研究提出了一种新方法,即茎环抑制介导的扩增(SLIMamp),用于在单个多重PCR反应中扩增重叠或平铺的扩增子。在SLIMamp PCR反应过程中,由重叠扩增子形成的茎环结构通过阻止引物退火来抑制其自身的额外扩增。使用SLIMamp策略,我们设计了一种下一代测序(NGS)检测方法,用于富集BRCA1和BRCA2的外显子区域,以便在Illumina MiSeq系统上进行测序。我们在研究中使用了35种细胞系DNA和6份患者血液DNA来评估该检测方法的性能。对于每个样本,所有靶向区域均成功扩增并测序,具有出色的覆盖均匀性和特异性。超过99%的总测序读数映射到人类参考基因组(hg19),超过99%的映射读数位于靶向外显子上。超过98%的碱基在平均覆盖度的0.20倍以上被覆盖,超过99%的碱基在平均深度的0.15倍以上被覆盖。在34个独立测序的样本中,所有变异均被可靠检测到,无假阳性或假阴性。SLIMamp为大量重叠扩增子的单管多重PCR扩增提供了一种强大的方法,这些扩增子可用于靶向下一代测序。